According to Worldometer's real-time statistics, as of about 6:30 on August 9th, Beijing time, a total of 203,389,937 confirmed cases of new coronary pneumonia worldwide, and a total of 4,306,374 deaths. Globally, there were 470,116 newly confirmed cases and 8,104 new deaths in a single day.
The above data shows that the new crown epidemic is still an important issue that many countries around the world need to face, and as the epidemic continues, the overall situation seems to have rebounded.
Among them, the emergence of the mutant new coronavirus delta has attracted the attention of many countries, and now many countries and regions in the world have been affected and impacted by this mutant virus.
WHO still needs US$11.5 billion in anti-epidemic funds
Under such circumstances, new news came from Reuters. According to its report, it emphasized that in order to better carry out the epidemic prevention and control work and curb the spread of the mutated new crown virus on a global scale, the WHO needs to obtain information from the outside world. More financial help, the main reason for this situation is the emergence of the delta mutant virus.
A draft report shows that the World Health Organization (WHO) desperately needs US$11.5 billion in funding to fight the more contagious Delta strain. The organization fears that rich countries have bypassed its new crown plan to some extent. .
According to the report, it is expected that in this document to be released afterwards, a large part of the funds required by the WHO to provide partners will be used to purchase testing equipment, oxygen and masks for poorer countries.
At the same time, a part of the funds will be provided for the purchase of the new crown vaccine, which will account for about a quarter of the proportion. In this way, the epidemic situation in some poor countries can also be controlled to prevent the overall situation from further deterioration.
The document is still under revision. It outlines the results and funding requirements of the Acceleration Program for Access to COVID-19 Tools (ACT-A), which is co-led by WHO and aims to distribute COVID-19 vaccines, drugs, and tests fairly throughout the world .
An ACT-A official, who asked not to be named, said that the plan was established at the beginning of the epidemic, but the funding is still severely insufficient. Its coordinator now admits that because many governments hope to solve the global epidemic in a “different way”. Demand, the lack of funds for the plan will continue to exist.
The document shows that, in view of this, the plan has cut funding requirements by nearly US$5 billion, but still requires US$16.8 billion, almost as much as the funds raised so far, of which US$7.7 billion is urgently needed.
The document also called for an additional US$3.8 billion in addition to the US$7.7 billion provided to exercise the option to purchase another 760 million doses of new crown vaccines, which will be delivered next year.
However, the report said that the WHO did not immediately comment
China will provide another 3 billion U.S. dollars in aid
Recently, at the ASEAN-China, Japan and South Korea 10+3 foreign ministers video conference, Chinese Foreign Minister Wang Yi said that China has now provided a large number of new crown vaccines worldwide, which is important for vaccination and epidemic prevention and control in many countries. As far as work is concerned, they all have a very important meaning.
Up to now, China has provided 750 million doses of vaccines. And, in the next 4 months, about 110 million doses of vaccines will continue to be provided.
Not only that, on the basis of actively providing the new crown vaccine to the outside world, China will also allocate 3 billion US dollars in funding for international assistance in the next three years. At the same time, China will continue to expand the vaccine supply to help countries accelerate the vaccination process.
In fact, China has already made a clear statement before, and after the outbreak of the epidemic, it has always taken active actions to participate in the global epidemic prevention and control.
Dr. Lei Dianliang, a scientist from the Department of Drug Technical Specifications and Standards of the Department of Medicines and Health Products Policy and Standards of WHO, recently accepted an interview with Xinhua News Agency reporters and pointed out that WHO hopes that countries that have the ability to provide vaccines abroad will include the vaccine in the "New Coronary Vaccine Implementation Plan". "The vaccine bank allows all countries to obtain vaccines fairly and effectively.
China has made great contributions in this regard and has also been highly recognized by the World Health Organization.
Some Chinese vaccine research and development units have cooperated with the UAE, Brazil, Pakistan and other countries to carry out phase III clinical trials. At the same time, they have also shipped the vaccine stock solution to Egypt, UAE, Pakistan, Malaysia and other countries for production and packaging, which has alleviated the shortage of vaccines in these countries to a certain extent. The phenomenon.
Anthony Zvey, a professor in the field of global health and development at the University of New South Wales in Australia, said in an interview with Xinhua News Agency that only the international community can work together to overcome the new crown epidemic. Fair vaccine distribution is crucial. The international community should work together to ensure that all Priority groups have received high-quality, safe and effective vaccines.
